John Patience - Mar 31, 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: Director, Chairman
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Stock symbol: BDSX
Transactions as of: Mar 31, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/2/2025, 04:25 PM
Previous filing: Dec 3, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Options Exercise		+46.7K	+13.82%		385K	Mar 31, 2025	Direct	F1
holding	BDSX	Common Stock						2.15M	Mar 31, 2025	By Patience Enterprises LP	F2
holding	BDSX	Common Stock						4.83M	Mar 31, 2025	By John Patience Living Trust dated 7/23/1993	F3
holding	BDSX	Common Stock						53K	Mar 31, 2025	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Options Exercise	$0	-46.7K	-100%	$0.00	0	Mar 31, 2025	Common Stock	46.7K		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3	The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
F4	These RSUs vested in full on March 31, 2025, and had no expiration date.